![](/img/cover-not-exists.png)
Cost-effectiveness in Canada of azacitidine for the treatment of higher-risk myelodysplastic syndromes
Levy, A.R., Zou, D., Risebrough, N., Buckstein, R., Kim, T., Brereton, N.Volume:
21
Language:
english
Journal:
Current Oncology
DOI:
10.3747/co.21.1311
Date:
November, 2013
File:
PDF, 1.98 MB
english, 2013